At the same time, some molecular subtypes of tumors cannot be explained by standard clinical parameters or commonly used biomarkers; the emergence of the renin–angiotensin system genes as a new prognostic marker of acute myeloid leukemia (AML) may solve this problem (32). Here, REN is linked to acute myeloid leukemia.